{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T19:56:48Z","timestamp":1775159808544,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010784","name":"Banco Santander","doi-asserted-by":"crossref","award":["BID\/ICI-FCSH\/SANTANDER UNIVERSIDADES-UBI\/2017"],"award-info":[{"award-number":["BID\/ICI-FCSH\/SANTANDER UNIVERSIDADES-UBI\/2017"]}],"id":[{"id":"10.13039\/100010784","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3499-9","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T10:08:54Z","timestamp":1563185334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Pedro","family":"Antunes","sequence":"first","affiliation":[]},{"given":"Dulce","family":"Esteves","sequence":"additional","affiliation":[]},{"given":"C\u00e9lia","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Sampaio","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Ascens\u00e3o","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Vilela","sequence":"additional","affiliation":[]},{"given":"Madalena","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Anabela Leal","family":"Amarelo","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Joaquim","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"3499_CR1","volume-title":"Cancer facts & figures 2018","author":"American Cancer Society","year":"2018","unstructured":"American Cancer Society. Cancer facts & figures 2018. Atlanta: American Cancer Society; 2018."},{"issue":"8","key":"3499_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017 Mar 10;35(8):893\u2013911. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.70.5400\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"1","key":"3499_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/EDE.0000000000000394","volume":"27","author":"PT Bradshaw","year":"2016","unstructured":"Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular disease mortality among breast cancer survivors. Epidemiology. 2016;27(1):6\u201313. \n                    https:\/\/doi.org\/10.1097\/EDE.0000000000000394\n                    \n                  .","journal-title":"Epidemiology."},{"issue":"3","key":"3499_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","volume":"164","author":"SAM Gernaat","year":"2017","unstructured":"Gernaat SAM, Ho PJ, Rijnberg N, Emaus MJ, Baak LM, Hartman M, et al. Risk of death from cardiovascular disease following breast cancer: a systematic review. Breast Cancer Res Treat. 2017;164(3):537\u201355. \n                    https:\/\/doi.org\/10.1007\/s10549-017-4282-9\n                    \n                  .","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3499_CR5","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr2901","volume":"13","author":"JL Patnaik","year":"2011","unstructured":"Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64. \n                    https:\/\/doi.org\/10.1186\/bcr2901\n                    \n                  .","journal-title":"Breast Cancer Res"},{"key":"3499_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-337","volume":"10","author":"LA Smith","year":"2010","unstructured":"Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010;10:337. \n                    https:\/\/doi.org\/10.1186\/1471-2407-10-337\n                    \n                  .","journal-title":"BMC Cancer"},{"issue":"2","key":"3499_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pcad.2010.06.007","volume":"53","author":"DB Sawyer","year":"2010","unstructured":"Sawyer DB, Peng X, Chen B, Pentassuglia L, Lim CC. Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog Cardiovasc Dis. 2010;53(2):105\u201313. \n                    https:\/\/doi.org\/10.1016\/j.pcad.2010.06.007\n                    \n                  .","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"3499_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","volume":"15","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovas Imaging. 2014;15(10):1063\u201393. \n                    https:\/\/doi.org\/10.1093\/ehjci\/jeu192\n                    \n                  .","journal-title":"Eur Heart J Cardiovas Imaging"},{"issue":"22","key":"3499_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981\u20138. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013777\n                    \n                  .","journal-title":"Circulation."},{"issue":"5","key":"3499_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979;91(5):710\u20137.","journal-title":"Ann Intern Med"},{"issue":"3","key":"3499_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.hfc.2011.03.005","volume":"7","author":"RM Witteles","year":"2011","unstructured":"Witteles RM, Fowler MB, Telli ML. Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented? Heart Fail Clin. 2011;7(3):333\u201344. \n                    https:\/\/doi.org\/10.1016\/j.hfc.2011.03.005\n                    \n                  .","journal-title":"Heart Fail Clin"},{"issue":"11","key":"3499_CR12","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/bjc.2011.439","volume":"105","author":"S Romano","year":"2011","unstructured":"Romano S, Fratini S, Ricevuto E, Procaccini V, Stifano G, Mancini M, et al. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Br J Cancer. 2011;105(11):1663\u20138. \n                    https:\/\/doi.org\/10.1038\/bjc.2011.439\n                    \n                  .","journal-title":"Br J Cancer"},{"issue":"25 Pt A","key":"3499_CR13","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751\u201368. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2014.01.073\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"3499_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jacc.2007.06.037","volume":"50","author":"LW Jones","year":"2007","unstructured":"Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3499_CR15","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","volume":"137","author":"LS Mehta","year":"2018","unstructured":"Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30\u201366. \n                    https:\/\/doi.org\/10.1161\/CIR.0000000000000556\n                    \n                  .","journal-title":"Circulation."},{"issue":"15","key":"3499_CR16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1136\/heartjnl-2012-303460","volume":"99","author":"JP Buckley","year":"2013","unstructured":"Buckley JP, Furze G, Doherty P, Speck L, Connolly S, Hinton S, et al. BACPR scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation. Heart. 2013;99(15):1069\u201371. \n                    https:\/\/doi.org\/10.1136\/heartjnl-2012-303460\n                    \n                  .","journal-title":"Heart."},{"issue":"2","key":"3499_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000819","volume":"5","author":"MJ Pearson","year":"2018","unstructured":"Pearson MJ, King N, Smart NA. Effect of exercise therapy on established and emerging circulating biomarkers in patients with heart failure: a systematic review and meta-analysis. Open Heart. 2018;5(2):e000819. \n                    https:\/\/doi.org\/10.1136\/openhrt-2018-000819\n                    \n                  .","journal-title":"Open Heart"},{"issue":"2","key":"3499_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pcad.2018.08.006","volume":"62","author":"Wesley J. Tucker","year":"2019","unstructured":"Tucker WJ, Beaudry RI, Liang Y, Clark AM, Tomczak CR, Nelson MD, et al. Meta-analysis of exercise training on left ventricular ejection fraction in heart failure with reduced ejection fraction: a 10-year update. Prog Cardiovasc Dis. 2018. \n                    https:\/\/doi.org\/10.1016\/j.pcad.2018.08.006\n                    \n                  .","journal-title":"Progress in Cardiovascular Diseases"},{"key":"3499_CR19","doi-asserted-by":"publisher","first-page":"Cd005001","DOI":"10.1002\/14651858.CD005001.pub3","volume":"9","author":"AC Furmaniak","year":"2016","unstructured":"Furmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016;9:Cd005001. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005001.pub3\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"key":"3499_CR20","doi-asserted-by":"publisher","first-page":"Cd011292","DOI":"10.1002\/14651858.CD011292.pub2","volume":"1","author":"IM Lahart","year":"2018","unstructured":"Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity for women with breast cancer after adjuvant therapy. Cochrane Database Syst Rev. 2018;1:Cd011292. \n                    https:\/\/doi.org\/10.1002\/14651858.CD011292.pub2\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3499_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ejhf.654","volume":"19","author":"JL Zamorano","year":"2017","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017;19(1):9\u201342. \n                    https:\/\/doi.org\/10.1002\/ejhf.654\n                    \n                  .","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"3499_CR22","doi-asserted-by":"publisher","first-page":"H213","DOI":"10.1152\/ajpheart.00646.2016","volume":"312","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Wu PT, Middlekauff HR, et al. Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions. Am J Physiol Heart Circ Physiol. 2017;312(2):H213\u2013h22. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00646.2016\n                    \n                  .","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"3499_CR23","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/circulationaha.117.024671","volume":"137","author":"JM Scott","year":"2018","unstructured":"Scott JM, Nilsen TS, Gupta D, et al. Exercise therapy and cardiovascular toxicity in cancer. Circulation. 2018;137(11):1176\u201391. \n                    https:\/\/doi.org\/10.1161\/circulationaha.117.024671\n                    \n                  .","journal-title":"Circulation."},{"issue":"3","key":"3499_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10549-017-4554-4","volume":"167","author":"AA Kirkham","year":"2018","unstructured":"Kirkham AA, Eves ND, Shave RE, Bland KA, Bovard J, Gelmon KA, et al. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Res Treat. 2018;167(3):719\u201329. \n                    https:\/\/doi.org\/10.1007\/s10549-017-4554-4\n                    \n                  .","journal-title":"Breast Cancer Res Treat"},{"key":"3499_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2017.07.037","volume":"245","author":"AA Kirkham","year":"2017","unstructured":"Kirkham AA, Shave RE, Bland KA, Bovard JM, Eves ND, Gelmon KA, et al. Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: a proof-of-concept RCT. Int J Cardiol. 2017;245:263\u201370. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2017.07.037\n                    \n                  .","journal-title":"Int J Cardiol"},{"issue":"3","key":"3499_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/2047487318811181","volume":"26","author":"Erin J Howden","year":"2018","unstructured":"Howden EJ, Bigaran A, Beaudry R, Fraser S, Selig S, Foulkes S, et al. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol. 2018:2047487318811181. \n                    https:\/\/doi.org\/10.1177\/2047487318811181\n                    \n                  .","journal-title":"European Journal of Preventive Cardiology"},{"issue":"7","key":"3499_CR27","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1249\/MSS.0b013e3181e0c112","volume":"42","author":"KH Schmitz","year":"2010","unstructured":"Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409\u201326. \n                    https:\/\/doi.org\/10.1249\/MSS.0b013e3181e0c112\n                    \n                  .","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"3499_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1249\/01.MSS.0000048831.15016.2A","volume":"35","author":"RJ Robertson","year":"2003","unstructured":"Robertson RJ, Goss FL, Rutkowski J, Lenz B, Dixon C, Timmer J, et al. Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc. 2003;35(2):333\u201341.","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"3499_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377\u201381.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"3499_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370. \n                    https:\/\/doi.org\/10.1093\/ehjci\/jev014\n                    \n                  .","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"3499_CR31","first-page":"1288","volume":"45","author":"RA Bruce","year":"1969","unstructured":"Bruce RA, McDonough JR. Stress testing in screening for cardiovascular disease. Bull N Y Acad Med. 1969;45(12):1288\u2013305.","journal-title":"Bull N Y Acad Med"},{"key":"3499_CR32","doi-asserted-by":"crossref","unstructured":"American Thoracic Society; American College of Chest Physicians. ATS\/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211\u2013277.","DOI":"10.1164\/rccm.167.2.211"},{"issue":"8","key":"3499_CR33","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"3499_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"3499_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1590\/S1806-37132010000500011","volume":"36","author":"J Franceschini","year":"2010","unstructured":"Franceschini J, Jardim JR, Fernandes AL, Jamnik S, Santoro IL. Reproducibility of the Brazilian Portuguese version of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire used in conjunction with its lung cancer-specific module. J Bras Pneumol. 2010;36(5):595\u2013602.","journal-title":"J Bras Pneumol"},{"key":"3499_CR36","volume-title":"Statistical power analysis for the social sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the social sciences. 2nd ed. New Jersey: Lawrence Erlbaum Associates; 1988.","edition":"2"},{"issue":"7","key":"3499_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cjca.2016.02.078","volume":"32","author":"SA Virani","year":"2016","unstructured":"Virani SA, Dent S, Brezden-Masley C, Clarke B, Davis MK, Jassal DS, et al. Canadian Cardiovascular Society Guidelines for evaluation and management of cardiovascular complications of cancer therapy. Can J Cardiol. 2016;32(7):831\u201341. \n                    https:\/\/doi.org\/10.1016\/j.cjca.2016.02.078\n                    \n                  .","journal-title":"Can J Cardiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3499-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:23:20Z","timestamp":1594668200000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3499-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3499"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3499-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.266\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.266\/v2","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval of this protocol was conferred by the Ethics Committee of the Centro CHVNG\/E (reference number 145\/2018\u20131). The trial will be conducted in compliance with the Declaration of Helsinki Ethical Principles (1975). Informed written consent will be obtained from all participants before enrolment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}